|
1. What will drive pharmacy growth in 2026? Full story
2. After industry pressure, Hims & Hers stops selling Wegovy pill Full story
3. Mark Cuban took on PBMs and lived to tell the story. Now he's talking to 500+ pharmacy executives in Chicago about lessons learned and what comes next. April 15-16. Save your seat here.
4. TrumpRx prices not always the lowest option Full story
5. Kaiser strike expands as 3,000 more workers walk out: 10 things to know Full story
6. New data: How value analysis and pharmacy leaders evaluate products now. Results here.
7. HHS to drop 340B rebate pilot after court rulings Full story
8. Ascension Illinois launches free drug program Full story
9. Pfizer gets FDA priority review for pediatric hemophilia treatment Full story
10. War breaks out over GLP-1 pills Full story
11. TrumpRx launches with discounts on 40 drugs: 5 takeaways Full story
12. Heart failure care is evolving. SSM Health + University of Glasgow share what clinicians should know — here.
Becker's Learning Opportunities
13. Drug shortages, margin pressure and 340B scrutiny are colliding. Learn how leaders can respond here.
14. Cardiology's shifting fast. How Advocate, Baptist Health South Florida + Fairview are adapting systemwide here.
15. Some health systems generate $20M annually from home infusion. Why many still hesitate — here.
16. Interested in more? See Becker’s full lineup of
webinars and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
